HR+/HER2- breast cancer involves cells that test positive for hormone receptors and negative for HER2 proteins. It's the most ...

and not yet reached in patients with HER2-positive breast cancer. "These results warrant larger prospective trials to refine brain MRI surveillance recommendations for stage IV breast cancer," the ...

Please provide your email address to receive an email when new articles are posted on . San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast ...

If breast cancer is diagnosed at an early stage, it has a higher chance of being cured. Therefore, it is important that you get tests done at regular intervals as it can help in early diagnosis of ...

Of the patients who completed the initial MRI, 14% had brain metastasis. The rates by subtype were: 18% in triple-negative breast cancer 15% in HER2-positive breast cancer 10% in hormone receptor ...

This makes it easy for cancer cells to spread to the bones, the lungs, the liver and the brain via the lymph and blood flows. Today, we will focus on a type called HER2-positive breast cancer ...

Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer. All patients with breast cancer who may be candidates ... knowledgeable and ...

hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. The Trop-2-directed antibody and topoisomerase inhibitor conjugate is approved for patients ...